ANXA5 and neoplasm: When evaluating the TME of CT26 tumor-bearing mice following various treatments (Supplementary Fig. 13a), we saw an increase in the M2 macrophage and a decrease in the M1 macrophage population following cisplatin treatment, which was reversed by subsequent administration of AnxA5-AH5 (Supplementary Fig. 13b).